ABL1 and non-small cell lung carcinoma: Following intracardiac injection of non-small cell lung cancer (NSCLC) cells in preclinical mouse models, it was found that the ABL kinases, specifically ABL2, drove metastasis of lung cancer cells to distal sites in the body including the brain [4–6].